Dynamic cancer drivers
Dynamic Cancer Drivers identify genes that causally drive one or more bio-pathological transitions during cancer progression by integrating pseudotime-informed causal inference applied to single-cell and bulk sequencing data.
Key Features:
- Causal Inference Framework: Employs causal inference to assess genes' effects on biological transitions during cancer progression.
- Pseudotime Analysis: Uses pseudotime trajectories to infer latent progression and locate critical moments of transition.
- Critical Event Detection and Causal Impact Assessment: Detects critical events where deviations from normal processes occur and assesses genes' causal impact on transitions after those events.
- Data Modalities: Applies to single-cell and bulk sequencing datasets, including applications in breast cancer.
- Improved Performance Over Static Methods: Demonstrates superior driver discovery compared with traditional static approaches by integrating temporal dynamics.
Scientific Applications:
- Enhanced Cancer Driver Discovery: Enables discovery of driver genes associated with specific bio-pathological transitions that static analyses may miss.
- Understanding Cancer Progression: Reveals sequential and causal relationships between genetic alterations and process-level transitions in cancer progression.
- Personalized Medicine: Identifies dynamic drivers specific to patients or subtypes to inform personalized treatment strategies.
Methodology:
Inferring pseudotime trajectories to model progression; identifying critical events where significant deviations from normal processes occur; and assessing the causal impact of genes on those transitions post-critical event.
Topics
Details
- License:
- Not licensed
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 11/2/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Cifuentes-Bernal AM, Pham VVH, Li X, Liu L, Li J, Duy Le T. Dynamic cancer drivers: a causal approach for cancer driver discovery based on bio-pathological trajectories. Briefings in Functional Genomics. 2022;21(6):455-465. doi:10.1093/bfgp/elac030. PMID:36124841. PMCID:PMC10467634.